Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hilgeroth

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Angewandte Chemie (International Ed. in English)|October 9, 2002
Using molecular symmetry to form new drugs: hydroxymethyl-substituted 3,9-diazatetraasteranes as the first class of symmetric MDR modulatorsAndreas Hilgeroth, Jósef Molnár, Eric De Clercq
Pharmaceutical Research|October 31, 2008
Impact of novel MDR modulators on human cancer cells: reversal activities and induction studiesClaudius Coburger, Hermann Lage, Josef Molnár, et al.
Molecules (Basel, Switzerland)|December 30, 2020
Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer TherapyHenry Döring, David Kreutzer, Christoph Ritter, et al.
Chembiochem : a European Journal of Chemical Biology|July 7, 2005
First insight into the symmetry and flexibility of membrane efflux pump P-glycoprotein by novel bifunctional modulatorsJörg Wollmann, Martin Richter, Jósef Molnár, et al.
Bioorganic & Medicinal Chemistry|May 30, 2007
Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitorsBurkhardt Voigt, Claudius Coburger, Joséf Monár, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2016
Discovery of novel N-phenyl 1,4-dihydropyridines with a dual mode of antimycobacterial activityFabian Lentz, Marc Hemmer, Norbert Reiling, et al.
Molecules (Basel, Switzerland)|June 10, 2022
Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. <i>Molecules</i> 2021, <i>26</i>, 18Henry Döring, David Kreutzer, Christoph Ritter, et al.
Pharmaceutical Research|November 24, 2004
Comparative effects on intestinal absorption in situ by P-glycoprotein-modifying HIV protease inhibitorsMartin Richter, Nóra Gyémánt, Joséf Molnár, et al.
European Journal of Medicinal Chemistry|March 7, 2006
Correlation of calculated molecular orbital energies of some phenothiazine compounds with MDR reversal propertiesAndreas Hilgeroth, Annamária Molnár, Josef Molnár, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of substituted 1,4-dihydroquinolines as novel promising class of P-glycoprotein inhibitors: First structure-activity relationships and bioanalytical studiesMarc Hemmer, Sören Krawczyk, Ina Simon, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Angewandte Chemie (International Ed. in English)|October 9, 2002
Using molecular symmetry to form new drugs: hydroxymethyl-substituted 3,9-diazatetraasteranes as the first class of symmetric MDR modulatorsAndreas Hilgeroth, Jósef Molnár, Eric De Clercq
Pharmaceutical Research|October 31, 2008
Impact of novel MDR modulators on human cancer cells: reversal activities and induction studiesClaudius Coburger, Hermann Lage, Josef Molnár, et al.
Molecules (Basel, Switzerland)|December 30, 2020
Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer TherapyHenry Döring, David Kreutzer, Christoph Ritter, et al.
Chembiochem : a European Journal of Chemical Biology|July 7, 2005
First insight into the symmetry and flexibility of membrane efflux pump P-glycoprotein by novel bifunctional modulatorsJörg Wollmann, Martin Richter, Jósef Molnár, et al.
Bioorganic & Medicinal Chemistry|May 30, 2007
Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitorsBurkhardt Voigt, Claudius Coburger, Joséf Monár, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2016
Discovery of novel N-phenyl 1,4-dihydropyridines with a dual mode of antimycobacterial activityFabian Lentz, Marc Hemmer, Norbert Reiling, et al.
Molecules (Basel, Switzerland)|June 10, 2022
Correction: Döring et al. Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy. <i>Molecules</i> 2021, <i>26</i>, 18Henry Döring, David Kreutzer, Christoph Ritter, et al.
Pharmaceutical Research|November 24, 2004
Comparative effects on intestinal absorption in situ by P-glycoprotein-modifying HIV protease inhibitorsMartin Richter, Nóra Gyémánt, Joséf Molnár, et al.
European Journal of Medicinal Chemistry|March 7, 2006
Correlation of calculated molecular orbital energies of some phenothiazine compounds with MDR reversal propertiesAndreas Hilgeroth, Annamária Molnár, Josef Molnár, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of substituted 1,4-dihydroquinolines as novel promising class of P-glycoprotein inhibitors: First structure-activity relationships and bioanalytical studiesMarc Hemmer, Sören Krawczyk, Ina Simon, et al.
Pageof 7